Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial

Background: A multicenter, double blinded, randomized phase III trial of the therapeutic cancer vaccine sialy1-Tn (STn) conjugated to keyhole-limpet Hemocyanin (KLH) was completed in an international cohort of 1,028 women with metastatic breast cancer who had nonprogressive disease or no evidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Nuhad K., Murray, James L., Zhou, Dapeng, Mittendorf, Elizabeth A., Sample, Dory, Tautchin, Michael, Miles, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753533/
https://www.ncbi.nlm.nih.gov/pubmed/23983823
http://dx.doi.org/10.7150/jca.7028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753533/
https://www.ncbi.nlm.nih.gov/pubmed/23983823
http://dx.doi.org/10.7150/jca.7028

Ejemplares similares